Confluence Investment Management’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-2,475
| Closed | -$315K | – | 315 |
|
|
2021
Q4 | $315K | Sell |
2,475
-703
| -22% | -$89.5K | ﹤0.01% | 261 |
|
|
2021
Q3 | $414K | Buy |
3,178
+84
| +3% | +$10.9K | 0.01% | 245 |
|
|
2021
Q2 | $550K | Buy |
3,094
+667
| +27% | +$119K | 0.01% | 231 |
|
|
2021
Q1 | $399K | Sell |
2,427
-121
| -5% | -$19.9K | 0.01% | 245 |
|
|
2020
Q4 | $421K | Sell |
2,548
-1,039
| -29% | -$172K | 0.01% | 245 |
|
|
2020
Q3 | $511K | Sell |
3,587
-183
| -5% | -$26.1K | 0.01% | 227 |
|
|
2020
Q2 | $416K | Sell |
3,770
-64
| -2% | -$7.06K | 0.01% | 237 |
|
|
2020
Q1 | $382K | Sell |
3,834
-409
| -10% | -$40.8K | 0.01% | 240 |
|
|
2019
Q4 | $605K | Buy |
4,243
+218
| +5% | +$31.1K | 0.01% | 225 |
|
|
2019
Q3 | $516K | Sell |
4,025
-218
| -5% | -$27.9K | 0.01% | 233 |
|
|
2019
Q2 | $605K | Buy |
4,243
+118
| +3% | +$16.8K | 0.01% | 225 |
|
|
2019
Q1 | $590K | Sell |
4,125
-535
| -11% | -$76.5K | 0.01% | 222 |
|
|
2018
Q4 | $578K | Sell |
4,660
-493
| -10% | -$61.1K | 0.01% | 232 |
|
|
2018
Q3 | $866K | Sell |
5,153
-300
| -6% | -$50.4K | 0.01% | 223 |
|
|
2018
Q2 | $940K | Buy |
+5,453
| New | +$940K | 0.02% | 221 |
|